Yahoo
    NasdaqCM - Nasdaq Real Time Price USD

    Anixa Biosciences, Inc. (ANIX)

    Get top stock picks
    3.0700 +0.0200 (+0.66%)
    At close: September 4 at 4:00:00 PM EDT
    3.3066 +0.2366 (+7.71%)
    After hours: September 4 at 7:38:22 PM EDT
    Get top stock picks
    Loading Chart for ANIX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026

    Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
    PR Newswire 3d ago
    Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy

    Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
    PR Newswire 13d ago
    Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    PR Newswire 19d ago
    Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting

    Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
    PR Newswire 4mo ago
    Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040

    Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
    PR Newswire 2mo ago
    Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs

    Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
    PR Newswire 4mo ago
    Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance

    Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance
    MarketBeat 6mo ago
    Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

    Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
    PR Newswire 4mo ago
    Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer

    Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
    PR Newswire 5mo ago
    /C O R R E C T I O N -- Anixa Biosciences, Inc./

    /C O R R E C T I O N -- Anixa Biosciences, Inc./
    PR Newswire 3mo ago
    Anixa Biosciences secures Korean patent for breast cancer vaccine

    Anixa Biosciences secures Korean patent for breast cancer vaccine
    Pharmaceutical Technology 2mo ago

    Related Tickers

    HOTH
    SILO
    RNXT
    AUTL
    INMB
    IMRX
    ARTV
    ABOS
    FOLD
    APVO
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: